Status:
COMPLETED
Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study
Lead Sponsor:
Landeskrankenhaus Feldkirch
Conditions:
Diabetes Mellitus Type I
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
8-18 years
Brief Summary
Diabetes mellitus type I is an increasing burden for more and younger children. Therapy should avoid long-term complications as macrovascular diseases and diabetic nephropathy, retinopathy and diabeti...
Detailed Description
The number of newly diagnosed patients with diabetes mellitus type I increases every year, with the patients becoming younger. The Austrian Diabetes Incidence Study Group demonstrated a significant an...
Eligibility Criteria
Inclusion
- 8 to 18 years suffering from diabetes mellitus type I for more than one year.
Exclusion
- Children who are unable to understand informed consent
- Diabetic children with duration of diabetes \< 1 year, age \<8 or \>18
- Insulin \< 0.5IE/kg/d
- Blood glucose before examination below 50 or above 350mg/dL
- Children with chronic diseases, handicapped children, children with cancer, chronic renal impairment, or neurological diseases
- Children who are on medications that can produce peripheral neuropathy, i.e antineoplastic drugs
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01512030
Start Date
December 1 2011
End Date
December 1 2015
Last Update
September 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Pediatrics, Academic Teaching Hospital, Landeskrankenhaus Feldkirch
Feldkirch, Austria, 6900